Reference Source

Sujie Pharmaceutical Ltd · 66-41 · JAPAN

For Sujie Pharmaceutical Ltd · 66-41 · JAPAN, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is JAPAN; product is Tatiomax Lyophilized Powder for Injection; product code is 65 G - - 99 Pigmentation Agent N.E.C; date published is 10/08/2013; address is Unknown , Tokyo, JAPAN, verified against its source on 2026-09-16.

Firm
Sujie Pharmaceutical Ltd verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
JAPAN verified
Address
Unknown , Tokyo, JAPAN verified
Date published
10/08/2013 verified
Product code
65 G - - 99 Pigmentation Agent N.E.C. verified
Product
Tatiomax Lyophilized Powder for Injection verified
FDA notes
Japan verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Sujie Pharmaceutical Ltd Date Published : 10/08/2013 Unknown , Tokyo, JAPAN 65 G - - 99 Pigmentation Agent N.E.C. Date Published: 10/08/2013 Desc: Tatiomax Lyophilized Powder for Injection Notes: Japan

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.